DALLAS: Neurotechnology company NeuroVigil has completed a second financing round in which the company issued equity securities at a pre-money valuation that was over two-and-a-half times the post-money valuations of the Series A financing rounds of Google and Facebook combined for less than 0.5% of its common stock.
The company’s 2011 seed financing round wherein NeuroVigil sold less than 2% of its common stock was at a pre-money valuation that was over twice the combined seed valuations of Google and Facebook.
“I continue to be impressed with the way NeuroVigil has met and exceeded its milestones” said noted seed investor Dr. Howard Morgan who led this financing round.